Table 1.
Clinicopathologic characteristics of patients in different immune/stromal score groups.
| Variables (%) | Immune score | Stromal score | ||||
|---|---|---|---|---|---|---|
| Low (n = 124) | High (n = 41) | p-value | Low (n = 80) | High (n = 85) | p-value | |
| Age (years) | 65.4 (24–88) | 64.6 (32–82) | 0.725 | 65.3 (24–88) | 65.1 (32–84) | 0.913 |
| Gender | 0.010 | 0.066 | ||||
| Female | 17 (13.7) | 13 (31.7) | 10 (12.5) | 20 (23.5) | ||
| Male | 107 (86.3) | 28 (68.3) | 70 (87.5) | 65 (76.5) | ||
| Invasiveness | <0.001 | <0.001 | ||||
| MIBC | 36 (29.0) | 26 (63.4) | 15 (18.8) | 47 (55.3) | ||
| NMIBC | 88 (71.0) | 15 (36.6) | 65 (81.2) | 38 (45.7) | ||
| Grade | 0.023 | 0.014 | ||||
| Low | 85 (68.5) | 20 (48.8) | 58 (72.5) | 46 (54.1) | ||
| High | 39 (31.5) | 21 (51.2) | 22 (27.5) | 39 (45.9) | ||
| Recurrence | 0.657 | 0.329 | ||||
| Yes | 30 (24.2) | 6 (14.6) | 25 (31.3) | 11 (12.9) | ||
| No | 58 (46.8) | 9 (22.0) | 40 (50.0) | 27 (31.8) | ||
| Progression | 0.289 | 0.681 | ||||
| Yes | 21 (16.9) | 10 (24.4) | 14 (17.5) | 17 (20.0) | ||
| No | 103 (83.1) | 31 (75.6) | 66 (82.5) | 68 (80.0) | ||
| Stage | 0.001 | <0.001 | ||||
| I | 88 (71.0) | 15 (36.6) | 65 (81.3) | 38 (44.7) | ||
| II | 15 (12.1) | 11 (26.8) | 6 (7.5) | 20 (23.5) | ||
| III | 13 (10.5) | 7 (17.1) | 4 (5.0) | 16 (18.8) | ||
| IV | 8 (6.4) | 8 (19.5) | 5 (6.2) | 11 (13.0) | ||